Kurt Malkames
Foot & Ankle Surgery · Greenbelt, MDNPI 1023544921
Payments from drug & device makers
Across 67 payments — averaging $33.61 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Stryker$819
- AbbVie$488
- Paratek Pharmaceuticals, Inc.$198
- Zimmer Biomet$122
- Biocomposites Inc$101
- Organogenesis Inc.$83
- plus $441 from 12 others
What the payments were for
- Travel & lodging$52823%
- Food & beverage$1,62172%
- Education$1035%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Stryker | 11 | $819 |
| AbbVie | 23 | $488 |
| Paratek Pharmaceuticals, Inc. | 11 | $198 |
| Zimmer Biomet | 1 | $122 |
| Biocomposites Inc | 1 | $101 |
| Organogenesis Inc. | 3 | $83 |
| Orthofix Medical, Inc. | 2 | $72 |
| Ortho Dermatologics, A Division Of Bausch Health US, LLC | 3 | $69 |
| Paragon 28, Inc. | 2 | $61 |
| Smith+Nephew | 2 | $37 |
| Kerecis Limited | 1 | $32 |
| Treace Medical Concepts, Inc. | 1 | $32 |
| Averitas Pharma Inc. | 1 | $29 |
| Ossio Inc | 1 | $27 |
| Amgen | 1 | $26 |
| Biowound Solutions, Inc. | 1 | $23 |
| Bioventus LLC | 1 | $21 |
| Integra Lifesciences Corporation | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$2,252 in reported general payments places this provider in the 45th percentile of 182 foot & ankle surgery providers in Maryland.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Ciclopirox | 84 | $1,804 |
| Ketoconazole | 57 | $1,309 |
| Mupirocin | 149 | $929 |
| Cephalexin | 52 | $540 |
| Ammonium Lactate | 25 | $327 |
| Gabapentin | 32 | $187 |
| Clindamycin Hcl | 13 | $58 |
Paid to pharmacies, not to this prescriber.
Other foot & ankle surgery in Greenbelt
- Lew SchonBaltimore$782K
- Stuart MillerBaltimore$624K
- Mark SpierGlen Burnie$400K
- Jeffrey BrodieTowson$366K
- Patrick MaloneyBaltimore$280K
- Gregory GuytonBaltimore$217K
- Walter HembreeBaltimore$166K
- Clifford JengBaltimore$157K
- Hummira AbawiColumbia$123K
- Eric HarmelinAnnapolis$118K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.